المؤلفون: Hossain MA; Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, 8100, Bangladesh. Electronic address: mdarafathossain745@gmail.com.

المصدر: European journal of pharmacology [Eur J Pharmacol] 2024 Sep 15; Vol. 979, pp. 176727. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/metabolism , Signal Transduction*/drug effects , Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/pharmacology , Molecular Targeted Therapy*, Humans ; Animals ; ras Proteins/metabolism ; ras Proteins/antagonists & inhibitors ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology

المؤلفون: Chukkalore D; Department of Internal Medicine, Staten Island University Hospital, New York, NY, USA., MacDougall K; Department of Hematology and Medical Oncology, the University of Oklahoma Medical Center, Oklahoma City, OK, USA., Master V; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA., Nazha B; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

المصدر: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 738-746.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Adrenocortical Carcinoma*/drug therapy , Adrenocortical Carcinoma*/therapy , Adrenocortical Carcinoma*/pathology , Immunotherapy*/methods , Molecular Targeted Therapy*/methods , Adrenal Cortex Neoplasms*/therapy , Adrenal Cortex Neoplasms*/drug therapy , Adrenal Cortex Neoplasms*/pathology , Adrenal Cortex Neoplasms*/genetics, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology

المؤلفون: Connell E; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Gerard É; Dermatology Department, CHU de Bordeaux, Bordeaux, France., Oules B; Dermatology Department, Cochin Hospital, Paris, France., Brunet-Possenti F; Dermatology Department, Bichat Claude-Bernard Hospital, Paris, France., Lamoureux A; Dermatology Department, Montpellier Cancer Institute, Montpellier, France., Bonnefille H; Dermatology Department, CHU de Nîmes, Nîmes, France., Mary-Prey S; Dermatology Department, CHU de Bordeaux, Bordeaux, France., Carrasquilla A; Dermatology Department, Leon Bérard Cancer Center, Lyon, France., Mouret S; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France., Kramkimel N; Dermatology Department, Cochin Hospital, Paris, France., Lesage C; Dermatology Department, CHU de Montpellier, Montpellier, France., Stoebner PE; Dermatology Department, CHU de Nîmes, Nîmes, France., Bartoli A; Radiology Department, Aix Marseille University, APHM, CERIMED, Marseille, France., Monestier S; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Correard F; Pharmacy Department, Aix Marseille University, APHM, Marseille, France., Gros A; Tumor Biology and Tumor Bank Department, University Hospital of Bordeaux, Bordeaux, France., Jeanson A; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Ouafik L; Oncobiology Department, Aix Marseille University, APHM, CNRS, INP, Inst Neurophysiopathol, Marseille, France., Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France., Tomasini P; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Charles J; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France., Amini-Adle M; Dermatology Department, Leon Bérard Cancer Center, Lyon, France., Malissen N; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.

المصدر: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. e1180-e1188.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/pathology , Melanoma*/genetics , Molecular Targeted Therapy*/methods, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Retrospective Studies ; Young Adult ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Skin Neoplasms/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Neoplasm Metastasis ; Membrane Proteins ; GTP Phosphohydrolases

المؤلفون: Radaelli S; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Merlini A; Department of Oncology, University of Turin, Orbassano, Italy.; Department of Oncology, San Luigi Gonzaga University Hospital, Orbassano, Italy., Khan M; Surgery, East Sussex NHS Healthcare, East Sussex, UK., Gronchi A; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

المصدر: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Sep; Vol. 24 (9), pp. 845-868. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/pathology , Sarcoma*/therapy , Sarcoma*/drug therapy , Immunotherapy*/methods , Molecular Targeted Therapy* , Neoadjuvant Therapy*/methods, Humans ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Combined Modality Therapy ; Soft Tissue Neoplasms/pathology ; Soft Tissue Neoplasms/therapy ; Soft Tissue Neoplasms/drug therapy ; Biomarkers, Tumor/metabolism

المؤلفون: Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, 589-8511, Japan. kawakami_h@med.kindai.ac.jp.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2024 Sep; Vol. 29 (9), pp. 1228-1236. Date of Electronic Publication: 2024 Apr 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/genetics , Esophagogastric Junction*/pathology , Molecular Targeted Therapy* , Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/genetics , Receptor, Fibroblast Growth Factor, Type 2*/genetics, Humans ; Claudins/genetics ; Cell Adhesion Molecules/genetics ; Antigens, Neoplasm/genetics

المؤلفون: Grewal US; Division of Hematology and Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Gaddam SJ; Division of Hematology and Oncology, Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA., Beg MS; Science 37 Inc, Durham, NC, USA., Brown TJ; Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

المصدر: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Sep; Vol. 24 (9), pp. 869-880. Date of Electronic Publication: 2024 Aug 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Biliary Tract Neoplasms*/drug therapy , Biliary Tract Neoplasms*/pathology , Biliary Tract Neoplasms*/genetics , Molecular Targeted Therapy* , Precision Medicine* , Mutation* , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/administration & dosage, Humans ; Drug Resistance, Neoplasm ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Survival Rate ; Disease Progression ; Animals

المؤلفون: Piercey O; Peter MacCallum Cancer Centre, Melbourne, Australia; Centre for Cancer Research, The University of Melbourne, Melbourne, Australia; Department of Clinical Pathology, The University of Melbourne, Australia. Electronic address: Oliver.piercey@petermac.org., Tie J; Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Hollande F; Centre for Cancer Research, The University of Melbourne, Melbourne, Australia; Department of Clinical Pathology, The University of Melbourne, Australia., Wong HL; Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Mariadason J; Olivia Newton John Cancer Wellness and Research Centre, Heidelberg, Australia; School of Medicine, La Trobe University, Melbourne, Australia., Desai J; Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2024 Sep; Vol. 23 (3), pp. 215-229. Date of Electronic Publication: 2024 Apr 28.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins B-raf*/genetics , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/therapy , Colorectal Neoplasms*/drug therapy , Mutation* , Molecular Targeted Therapy*/methods, Humans ; Drug Resistance, Neoplasm/genetics ; Neoplasm Metastasis

المؤلفون: Eichhorst B; Department I for Internal Medicine, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, University of Cologne, Cologne, Germany., Ghia P; Medical School, Università Vita-Salute San Raffaele, Milan; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen, Denmark., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Gregor M; Division of Hematology, Luzerner Kantonsspital, Luzern, Switzerland., Hallek M; Department I for Internal Medicine, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, University of Cologne, Cologne, Germany; Cluster of Excellence-Cologne Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany., Jerkeman M; Department of Oncology, Skåne University Hospital and Lund University, Lund, Sweden., Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm (CCCU), University Hospital of Ulm, Ulm, Germany.

مؤلفون مشاركون: ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 762-768. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Molecular Targeted Therapy*/methods, Humans ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Liu L; Hunan University of Chinese Medicine, Changsha, China., Zhang C; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China., Liu H; Guangdong Provincial People's Hospital Zhuhai Hospital (Zhuhai Golden Bay Center Hospital), Zhuhai, China., Luo H; The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, China., Cao R; Hunan University of Chinese Medicine, Changsha, China., Xiao M; China Pharmaceutical University, Nanjing, China., Zou P; Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, China., Xie Z; Hunan University of Chinese Medicine, Changsha, China., Gong H; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.; International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, China.; Toxicology Counseling Center of Hunan Province (TCCH), Changsha, China., Ma R; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.; International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, China.; Toxicology Counseling Center of Hunan Province (TCCH), Changsha, China., Yan M; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.; International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, China.; Toxicology Counseling Center of Hunan Province (TCCH), Changsha, China., Jiang Z; The First Affiliated Hospital of Hunan Traditional Chinese Medical College, Zhuzhou, China.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Sep; Vol. 23 (9), pp. 1199-1205. Date of Electronic Publication: 2024 Feb 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Lysis Syndrome*/etiology , United States Food and Drug Administration* , Liver Neoplasms*/drug therapy , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/administration & dosage , Molecular Targeted Therapy*/adverse effects, Humans ; United States ; Time Factors

المؤلفون: Wang Y; Department of Respiratory Medicine, Thoracic Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China., Zheng J; Department of Respiratory Medicine, Thoracic Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China., Zhu Y; Department of Respiratory Medicine, Thoracic Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China., Zhou J; Department of Respiratory Medicine, Thoracic Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.

المصدر: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2024 Aug 20; Vol. 27 (8), pp. 593-604.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Internet ISSN: 1999-6187 (Electronic) Linking ISSN: 10093419 NLM ISO Abbreviation: Zhongguo Fei Ai Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/diagnosis , Lung Neoplasms*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/diagnosis , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Mutation* , Molecular Targeted Therapy*, Humans ; Protein Kinase Inhibitors/therapeutic use